| Primary |
| Chronic Myeloid Leukaemia |
79.1% |
| Acute Lymphocytic Leukaemia |
10.4% |
| Chromosome Analysis Abnormal |
3.3% |
| Product Used For Unknown Indication |
2.0% |
| Acute Myeloid Leukaemia |
1.4% |
| Leukaemia |
1.0% |
| Acute Leukaemia |
0.4% |
| Blast Crisis In Myelogenous Leukaemia |
0.4% |
| Acute Lymphocytic Leukaemia Recurrent |
0.2% |
| Bladder Cancer |
0.2% |
| Breast Cancer |
0.2% |
| Leukaemia Recurrent |
0.2% |
| Lung Carcinoma Cell Type Unspecified Stage 0 |
0.2% |
| Lymphocytic Leukaemia |
0.2% |
| Myeloid Leukaemia |
0.2% |
| Terminal State |
0.2% |
| Tooth Extraction |
0.2% |
| Vaginal Haemorrhage |
0.2% |
|
| Rash |
15.4% |
| Pyrexia |
8.9% |
| Death |
7.7% |
| Skin Exfoliation |
7.7% |
| Platelet Count Decreased |
5.7% |
| Pancreatitis |
5.3% |
| White Blood Cell Count Decreased |
4.9% |
| Headache |
4.5% |
| Nausea |
4.5% |
| Weight Decreased |
4.5% |
| Vomiting |
4.0% |
| Hypertension |
3.6% |
| Constipation |
3.2% |
| Pain |
3.2% |
| White Blood Cell Count Increased |
3.2% |
| Full Blood Count Decreased |
2.8% |
| Lipase Increased |
2.8% |
| Pain In Extremity |
2.8% |
| Red Blood Cell Count Decreased |
2.8% |
| Disease Progression |
2.4% |
|
| Secondary |
| Acute Lymphocytic Leukaemia |
40.0% |
| Chromosome Analysis Abnormal |
40.0% |
| Acute Myeloid Leukaemia |
12.0% |
| Product Used For Unknown Indication |
8.0% |
|
| Thrombocytopenia |
66.7% |
| Malignant Neoplasm Progression |
33.3% |
|
| Concomitant |
| Myeloid Leukaemia |
60.0% |
| Discomfort |
20.0% |
| Chronic Myeloid Leukaemia |
13.3% |
| Infection Prophylaxis |
6.7% |
|
| Speech Disorder |
50.0% |
| Nausea |
16.7% |
| Thoracic Cavity Drainage |
16.7% |
| Weight Decreased |
16.7% |
|
